SCHEMBL7479523

SCHEMBL7479523

O=C(O)Cc1c(C(=O)c2ccc3c(c2)CCO3)[nH]c2cc(Cl)ccc12

nearest known ligand 0.57

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 3/20 0.55
▸ GPR17 Q13304 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7483632 0.89 PTGS2 (0.52) PTGS2GPR17MEN1TSHRKMT2A
SCHEMBL7477207 0.85 PTGS2 (0.53) PTGS2GPR17MEN1TSHRKMT2A
SCHEMBL6169004 0.81 PTGS2 (0.60) PTGS2GPR17
SCHEMBL7479527 0.80 ABCB11 (0.40) —
SCHEMBL6170125 0.80 PTGS2 (0.59) PTGS2GPR17
SCHEMBL7478491 0.78 PTGS2 (0.53) PTGS2GPR17
SCHEMBL6169720 0.78 PTGS2 (0.57) PTGS2GPR17
SCHEMBL6170150 0.78 PTGS2 (0.57) PTGS2GPR17
SCHEMBL6169955 0.78 PTGS2 (0.57) PTGS2GPR17
SCHEMBL6169769 0.78 PTGS2 (0.59) PTGS2GPR17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1065204-B1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors PFIZER (US) 2002-04-10 — — EP claimed
US-6303628-B1 FOR THE TREATMENT OF A MEDICAL CONDITION IN WHICH PROSTAGLANDINS ARE IMPLICATED AS PATHOGENS IN MAMMALS PFIZER INC 2001-10-16 — — US claimed
EP-1065204-A1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors PFIZER INC. (US) 2001-01-03 — — EP claimed
EP-1065204-B1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors PFIZER (US) 2002-04-10 — — EP disclosed
US-6303628-B1 FOR THE TREATMENT OF A MEDICAL CONDITION IN WHICH PROSTAGLANDINS ARE IMPLICATED AS PATHOGENS IN MAMMALS PFIZER INC 2001-10-16 — — US disclosed
EP-1065204-A1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors PFIZER INC. (US) 2001-01-03 — — EP disclosed
Send feedback